Clinical Trial Update: Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating adjuvant chemotherapy with or without immunotherapy after radical surgery for resectable gastric or gastroesophageal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Liaoning Cancer Hospital & Institute | Conditions: Gastric / Gastroesophageal Junction Adenocarcinoma | Phase 4 | Status: NOT_YET_RECRUITING